Jintian Pharmaceutical Group Limited provided earnings guidance for the six months ended June 30, 2014. For the six months, the company expects to record a substantial increase in its consolidated net profit for the six months ended 30 June 2014 as compared to that for the corresponding period in 2013, which is mainly attributable to a substantial growth in both the retail and distribution businesses.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 HKD | +1.85% | -1.79% | -44.44% |
02-28 | Universal Health International Group's Fiscal H1 Loss Narrows | MT |
02-27 | Universal Health International Group Holding Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-44.44% | 4.61M | |
+23.03% | 72.92B | |
-1.52% | 23.8B | |
+3.67% | 8.38B | |
+8.55% | 8.33B | |
-23.71% | 7.66B | |
+15.20% | 5.13B | |
-6.90% | 4.18B | |
+2.68% | 4.06B | |
+5.56% | 3.91B |
- Stock Market
- Equities
- 2211 Stock
- News Universal Health International Group Holding Limited
- Jintian Pharmaceutical Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2014